Vitro Diagnostics Inc (VODG) financial statements (2021 and earlier)

Company profile

Business Address 4621 TECHNOLOGY DRIVE
GOLDEN, CO 80403
State of Incorp. NV
Fiscal Year End October 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5325
Cash and cash equivalents5325
Receivables1019 2
Inventory, net of allowances, customer advances and progress billings29222527
Inventory29222527
Prepaid expense  0
Other undisclosed current assets5352
Total current assets:49473337
Noncurrent Assets
Property, plant and equipment44421117
Long-term investments and receivables   544
Long-term investments   544
Intangible assets, net (including goodwill)12151821
Intangible assets, net (excluding goodwill)12151821
Regulated entity, other noncurrent assets  170 
Other noncurrent assets 1 
Other undisclosed noncurrent assets111(156)(533)
Total noncurrent assets:67594349
TOTAL ASSETS:1161067685
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,2781,25628 
Accounts payable644828 
Accrued liabilities82  
Employee-related liabilities1,2061,206  
Debt823  
Deferred compensation liability  1,2031,190
Due to related parties3430  
Other undisclosed current liabilities1,174 779650
Total current liabilities:2,4951,3092,0101,840
Noncurrent Liabilities
Other undisclosed noncurrent liabilities3 (1,953)(1,944)
Total noncurrent liabilities:3 (1,953)(1,944)
Other undisclosed liabilities 957  
Total liabilities:2,4982,26656(104)
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,382)(2,160)(1,933)(1,755)
Common stock2020 19
Additional paid in capital5,4565,4335,4135,383
Accumulated deficit(7,859)(7,613)(7,366)(7,155)
Other undisclosed stockholders' equity attributable to parent  20(1)
Stockholders' equity attributable to noncontrolling interest  (1,933) 
Other undisclosed stockholders' equity  3,8871,944
Total stockholders' equity:(2,382)(2,160)20189
TOTAL LIABILITIES AND EQUITY:1161067685

Income statement (P&L) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Revenues781202328
Revenue, net99952328
Cost of revenue
(Cost of Goods and Services Sold)
(22)(23) (15)
Other undisclosed gross profit7(25)(3) 
Gross profit:63722013
Operating expenses(236)(399)(229)(37)
Other undisclosed operating income1515658 
Operating loss:(158)(171)(151)(24)
Interest and debt expense(88)75(60) 
Loss from continuing operations before equity method investments, income taxes:(246)(96)(211)(24)
Other undisclosed loss from continuing operations before income taxes (151)  
Net loss:(246)(247)(211)(24)
Other undisclosed net loss attributable to parent   (203)
Net loss available to common stockholders, diluted:(246)(247)(211)(228)

Comprehensive Income ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Net loss:(246)(247)(211)(24)
Comprehensive loss, net of tax, attributable to parent:(246)(247)(211)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: